LEZLIE MATHEWS: Open Payments
NPI 1760570550 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,138 in 69 payments from 17 companies in 2025. Trend: 2023 $2,439 · 2024 $1,568 · 2025 $2,138
Food & beverage: $1,360Travel & lodging: $778
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 14 | $953 |
| E.R. Squibb & Sons, L.L.C. | 21 | $352 |
| Recor Medical Inc | 4 | $179 |
| Novartis Pharmaceuticals Corporation | 6 | $126 |
| Philips North America LLC | 5 | $105 |
| ABIOMED | 1 | $94 |
| Amgen Inc. | 3 | $47 |
| Medtronic, Inc. | 2 | $47 |
| BIOTRONIK INC. | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
Products named: CARDIOMEMS, CAMZYOS, Paradise Ultrasound Renal Denervation System, LEQVIO, Ambulatory Monitoring & Diagnostics Undivided, ELIQUIS, Repatha, MICRA.
Industry payments across MS — which companies pay providers there.
